Retirement Guys Formula LLC Has $769,000 Position in Colgate-Palmolive (NYSE:CL)

Retirement Guys Formula LLC lifted its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 15.3% during the fourth quarter, HoldingsChannel reports. The firm owned 8,463 shares of the company’s stock after acquiring an additional 1,125 shares during the quarter. Retirement Guys Formula LLC’s holdings in Colgate-Palmolive were worth $769,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CL. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $36,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the third quarter worth about $42,000. Synergy Asset Management LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $49,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive during the third quarter worth about $53,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $87.35 on Wednesday. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The business has a fifty day moving average price of $90.14 and a 200-day moving average price of $96.69. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The firm has a market capitalization of $71.37 billion, a P/E ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm earned $0.87 EPS. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on CL shares. UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Raymond James restated an “outperform” rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $101.16.

Check Out Our Latest Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.